Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value Inas AlhudiriChristopher NolanCaroline Chapman Research Open access 05 April 2024
BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization Rinat YerushalmiAdi PomerantzLuna Kadouri Clinical trial Open access 03 April 2024
Long-term effects of aromatase inhibitor withdrawal on bone mineral density in early breast cancer patients: 10-year follow-up results of the BREX study Carl BlomqvistLeena VehmanenTiina Saarto Clinical trial Open access 01 April 2024
First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN N. Martínez-JañezM. Bellet EzquerraF. Moreno Antón Original Laboratory Investigation Open access 01 April 2024
A whole food, plant-based randomized controlled trial in metastatic breast cancer: feasibility, nutrient, and patient-reported outcomes Erin K. CampbellThomas M. CampbellLuke J. Peppone Clinical trial Open access 30 March 2024
Lifestyle interventions with dietary strategies after breast cancer diagnosis: a systematic review Acadia W. BuroTam NguyenTiffany L. Carson Review 29 March 2024
Ethnic inequities in use of breast conserving surgery and radiation therapy in Aotearoa/New Zealand: which factors contribute? Leah BoyleRoss LawrensonSandar Tin Tin Research Open access 27 March 2024
The effects of low HER2 expression on survival in patients with metastatic breast cancer treated with CDK 4/6 inhibitors: a multicenter retrospective study Murad GuliyevGülin Alkan ŞenNebi Serkan Demirci Research Open access 25 March 2024
Five-year survival prognosis of young, middle-aged, and elderly adult female invasive breast cancer patients by clinical and lifestyle characteristics Yu-Tung TengYong Alison WangJason J. Liu Research Open access 25 March 2024
Comparison of long-term oncologic outcomes of central lumpectomy and conventional breast-conserving surgery for invasive breast cancer: propensity score matching analysis Ji-Jung JungJong-Ho CheunWonshik Han Clinical trial Open access 25 March 2024
Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancer Henry G. KaplanAlexa K. DowdellBrian D. Piening Preclinical study Open access 24 March 2024
Germline pathogenic variants associated with triple-negative breast cancer in US Hispanic and Guatemalan women using hospital and community-based recruitment strategies Jesica M Godinez ParedesIsabel RodriguezMichael Dean Original Laboratory Investigation Open access 23 March 2024
Racial disparities in initiation of chemotherapy among breast cancer patients with discretionary treatment indication in the state of Georgia Lindsay J. CollinJade JonesLauren E. McCullough Research Open access 22 March 2024
Development of a core set of outcome measures to be applied toward breast cancer-related lymphedema core outcome domains David DoubblesteinLinda KoehlerJane Armer Review Open access 22 March 2024
Trends in socioeconomic inequalities in breast cancer mortality in Canada: 1992–2019 Nazanin NasiriMin HuMohammad Hajizadeh Epidemiology 19 March 2024
The distribution of breast density in women aged 18 years and older Dilukshi PereraSarah PirikahuJennifer Stone Epidemiology Open access 18 March 2024
Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines: a clinical implementation study Annelie AugustinssonNiklas LomanHans Ehrencrona Research Open access 16 March 2024
Global prevalence and factors associated with preoperative depression in women undergoing breast surgery: a meta-analysis and meta-regression Celest Su Yi LeoLing Jie ChengHonggu He Review 16 March 2024
False negative breast cancers on imaging and associated risk factors: a single institution six-year analysis Jordan FranklinJody HayesBaşak Dogan Epidemiology 14 March 2024
Aging-accumulated methylmalonic acid serum levels at breast cancer diagnosis are not associated with distant metastases Qi WuSigrid HatseHans Wildiers Original Laboratory Investigation 13 March 2024
Immediate and delayed risk of breast cancer associated with classic lobular carcinoma in situ and its variants Hannah L. ChungLavinia P. MiddletonGary J. Whitman Original Laboratory Investigation 12 March 2024
Infertility and risk of postmenopausal breast cancer in the women’s health initiative Leslie V. FarlandKimberly E. LindHolly R. Harris Epidemiology 09 March 2024
Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab María GionJuan José García-MosqueraJavier Cortés Research 08 March 2024
Intertumoral heterogeneity of bifocal breast cancer: a morphological and molecular study Kai FinsterbuschPaul J. van DiestCornelia M. Focke Research 07 March 2024
Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes Esmeralda Garcia-TorralbaMiguel Pérez RamosFrancisco Ayala de la Peña Epidemiology Open access 07 March 2024
Identify risk factors affecting participation of Turkish women in mammography screening for breast cancer prevention Esra BayrakçekenSüheyla YaralıÖmer Alkan Epidemiology Open access 07 March 2024
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial Angeline GinzacIoana MolnarMarie-Ange Mouret-Reynier Clinical trial Open access 07 March 2024
Survival analysis of patients with brain metastases at initial breast cancer diagnosis over the last decade Jorge AvilaJulieta LeoneJosé P. Leone Research 07 March 2024
A whole-food, plant-based randomized controlled trial in metastatic breast cancer: weight, cardiometabolic, and hormonal outcomes Thomas M. CampbellErin K. CampbellLuke J. Peppone Clinical trial Open access 06 March 2024
Survival among patients with untreated metastatic breast cancer: “What if I do nothing?” Jennifer K. PlichtaSamantha M. ThomasE. Shelley Hwang Epidemiology 05 March 2024
Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis Hongxia SunEun Young KangAysegul A. Sahin Research 05 March 2024
Burden of female breast cancer in India: estimates of YLDs, YLLs, and DALYs at national and subnational levels based on the national cancer registry programme Vaitheeswaran KulothunganThilagavathi RamamoorthyPrashant Mathur Epidemiology Open access 04 March 2024
Primary MALT lymphoma of the breast: pathological and radiological characteristics Yukiko ShibaharaJan M. A. DelabieSusan J. Done Original Laboratory Investigation 01 March 2024
Liver tropism of ER mutant breast cancer is characterized by unique molecular changes and immune infiltration Yang WuZheqi LiBin Luo Original Laboratory Investigation 01 March 2024
Development of a core outcome set for breast cancer-related lymphedema: a Delphi study David DoubblesteinLinda KoehlerJane Armer Original Laboratory Investigation Open access 29 February 2024
Pro-vegetarian dietary pattern and risk of breast cancer: a case–control study Yasaman HosseiniPegah Hadi SichaniBahram Rashidkhani RESEARCH 28 February 2024
Opportunities for personalised follow-up in breast cancer: the gap between daily practice and recurrence risk Madelon M. VoetsNoa S. HassinkSabine Siesling Epidemiology Open access 26 February 2024
Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers: a single institution experience Hila BufmanRenata FaermannMiri Sklair-Levy Epidemiology Open access 21 February 2024
Preoperative factors that predict pathologic nodal involvement in early-stage HER2+ breast cancer: selecting cT1cN0 patients for treatment with neoadjuvant chemotherapy versus upfront surgery Sohayb FalehIpshita PrakashStephanie M. Wong Epidemiology 21 February 2024
Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry Sandra M. E. GeurtsKhava I. E. IbragimovaVivianne C. G. Tjan-Heijnen Epidemiology Open access 21 February 2024
Geographical distance predicts psychiatric treatment retention for Hispanic women with comorbid major depression and breast cancer Ying ChenJohn C. MarkowitzDavid J. Hellerstein Clinical trial 20 February 2024
Reassessing treatment strategies for DCIS: analysis of survival and recurrence patterns Kefah MokbelMunaser Alamoodi Letter to the Editor 15 February 2024
Searching for the “Holy Grail” of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA) Lucy GaoArielle MedfordJeffrey Peppercorn Review 15 February 2024
Socio-cultural and financial issues against breast cancer screening behaviour among eligible Indian women: evidence for action Shibaji GuptaSharmistha Sinha GuptaSonu Goel Epidemiology 12 February 2024 Pages: 169 - 179
The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy Raz MutaiIryna KuchukHadar Goldvaser Clinical trial Open access 12 February 2024
Comparison of long-term oncological outcomes after central lumpectomy versus nipple-sparing breast-conserving surgery for centrally located breast cancer: a propensity score-matched study Yung-Huyn HwangTae-Kyung YooByung Ho Son Clinical trial 08 February 2024 Pages: 117 - 125
Real-world treatment patterns and clinical outcomes in patients treated with eribulin after prior phosphoinositide 3-Kinase inhibitor treatment for metastatic breast cancer Ravi K. GoyalJingchuan ZhangPeter A. Kaufman Original Laboratory Investigation Open access 04 February 2024 Pages: 201 - 210
Investigating the role of tumour-to-skin proximity in predicting nodal metastasis in breast cancer Thiviya SivakanthanJ. TannerA. Agrawal Clinical trial Open access 03 February 2024 Pages: 109 - 116
MRI-visualized T2 hyperintense breast lesions: identifying clinical and imaging factors linked to malignant biopsy outcomes Mary Beth BissellSareh KeshavarsiVivianne Freitas Epidemiology 02 February 2024 Pages: 159 - 168
Information needs in breast reconstruction after mastectomy: a qualitative analysis of free-text responses from 2077 women Kim WuytsVicki DurstonVictoria White Epidemiology Open access 01 February 2024 Pages: 147 - 157